Chuo WH - Search Results

1

Effective inhibition of MERS-CoV infection by resveratrol.

Lin SC, Ho CT, Chuo WH, Li S, Wang TT, Lin CC. Lin SC, et al. Among authors: chuo wh. BMC Infect Dis. 2017 Feb 13;17(1):144. doi: 10.1186/s12879-017-2253-8. BMC Infect Dis. 2017. PMID: 28193191 Free PMC article.

2

Sclareol attenuates the development of atopic dermatitis induced by 2,4-dinitrochlorobenzene in mice.

Wu PC, Chuo WH, Lin SC, Lehman CW, Lien CZ, Wu CS, Lin CC. Wu PC, et al. Among authors: chuo wh. Immunopharmacol Immunotoxicol. 2019 Feb;41(1):109-116. doi: 10.1080/08923973.2018.1555846. Epub 2019 Feb 1. Immunopharmacol Immunotoxicol. 2019. PMID: 30704333

3

Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions.

Wu CS, Hu SC, Lan CC, Chen GS, Chuo WH, Yu HS. Wu CS, et al. Among authors: chuo wh. Kaohsiung J Med Sci. 2008 Apr;24(4):180-9. doi: 10.1016/S1607-551X(08)70115-3. Kaohsiung J Med Sci. 2008. PMID: 18424354 Free article. Clinical Trial.

4

Alantolactone Suppresses Proliferation and the Inflammatory Response in Human HaCaT Keratinocytes and Ameliorates Imiquimod-Induced Skin Lesions in a Psoriasis-Like Mouse Model.

Chuo WH, Tung YT, Wu CL, Bracci NR, Chang YK, Huang HY, Lin CC. Chuo WH, et al. Life (Basel). 2021 Jun 25;11(7):616. doi: 10.3390/life11070616. Life (Basel). 2021. PMID: 34202301 Free PMC article.

5

Preparation and pharmacological evaluation of physostigmine-loaded polyisobutylcyanoacrylate nanoparticles in rats.

Tsai TR, Chuo WH, Lin CW, Cham TM. Tsai TR, et al. Among authors: chuo wh. Kaohsiung J Med Sci. 1998 Jan;14(1):13-8. Kaohsiung J Med Sci. 1998. PMID: 9519684

6

Optimization of Formulation Parameters in Preparation of Fructus ligustri lucidi Dropping Pills by Solid Dispersion Using 2³ Full Experimental Design.

Wu KR, Chuo WH, Huang YT. Wu KR, et al. Among authors: chuo wh. Pharmaceuticals (Basel). 2022 Nov 19;15(11):1433. doi: 10.3390/ph15111433. Pharmaceuticals (Basel). 2022. PMID: 36422563 Free PMC article.

7

An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatment drug) sustained-release pellets by microdialysis technique in the rabbit model.

Huang YT, Cheng CJ, Lai TF, Tsai TR, Tsai TH, Chuo WH, Cham TM. Huang YT, et al. Among authors: chuo wh. Neurosci Lett. 2007 Apr 18;416(3):302-6. doi: 10.1016/j.neulet.2007.02.019. Epub 2007 Feb 12. Neurosci Lett. 2007. PMID: 17336457

8

Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties.

Huang YT, Tsai TR, Cheng CJ, Cham TM, Lai TF, Chuo WH. Huang YT, et al. Among authors: chuo wh. Drug Dev Ind Pharm. 2007 Nov;33(11):1183-91. doi: 10.1080/03639040701377334. Drug Dev Ind Pharm. 2007. PMID: 18058314

9

Preparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsions.

Chang LC, Wu CL, Liu CW, Chuo WH, Li PC, Tsai TR. Chang LC, et al. Among authors: chuo wh. J Biomed Nanotechnol. 2011 Aug;7(4):558-67. doi: 10.1166/jbn.2011.1315. J Biomed Nanotechnol. 2011. PMID: 21870460

10

Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties.

Huang YT, Tsai TR, Cheng CJ, Cham TM, Lai TF, Chuo WH. Huang YT, et al. Among authors: chuo wh. Drug Dev Ind Pharm. 2007 Apr;33(4):403-16. doi: 10.1080/03639040601031890. Drug Dev Ind Pharm. 2007. PMID: 17523005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page